THE DEVELOPMENT OF POST-INFLAMMATORY GASTROINTESTINAL SYMPTOMS IN PATIENTS WHO HAVE HAD AN IMMUNE CHECKPOINT INHIBITOR-RELATED ADVERSE EVENT IN THE GASTROINTESTINAL TRACT

被引：0
|
作者：
Varma, Sanskriti
Staller, Kyle
Dougan, Michael
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1356
引用
收藏
页码：S1038 / S1038
页数：1
相关论文
共 50 条
  • [21] Skin pathologic change evaluation of the patients who had EGFR inhibitor-related skin adverse events
    Oh, S. Y.
    Ji, J. H.
    Kim, Y.
    Lee, S.
    Huh, S. J.
    Lee, J. H.
    Song, K-H.
    Son, C. H.
    Kang, J. H.
    Roh, M. S.
    Kim, J. M.
    Choo, J. E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] Sargramostim for Prophylactic Management of Gastrointestinal Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy for Cancer
    Dougan, Michael
    Nguyen, Long H.
    Buchbinder, Elizabeth I.
    Lazarus, Hillard M.
    CANCERS, 2024, 16 (03)
  • [23] Characterizing immune checkpoint inhibitor-related cutaneous adverse reactions: A comprehensive analysis of FDA adverse event reporting system (FAERS) database
    Esen, Bugra Han
    Ozbek, Lasin
    Oguz, Sinem
    Selcukbiricik, Fatih
    HELIYON, 2024, 10 (13)
  • [24] Analysis of immune-related adverse events in gastrointestinal malignancy patients treated with immune checkpoint inhibitors
    Niu, Chengu
    Zhu, Kaiwen
    Zhang, Jing
    Joshi, Utsav
    Liu, Hongli
    Zahid, Salman
    Jadhav, Nagesh
    Okolo, Patrick I.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (07) : 1261 - 1271
  • [25] An Investigation of Nine Patients with Gastrointestinal Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors
    Miyahara, Koichi
    Noda, Takahiro
    Ito, Yoichiro
    Hidaka, Hidenori
    Fujimoto, Shun
    Takedomi, Hironobu
    Akutagawa, Takashi
    Sakata, Yasuhisa
    Shimamura, Takuya
    Tominaga, Naoyuki
    Yamaguchi, Daisuke
    Fujimoto, Kazuma
    DIGESTION, 2020, 101 (01) : 60 - 65
  • [26] Exploring immune checkpoint inhibitor-related adverse events in pediatric cancer patients: A pharmacovigilance analysis of VigiBase and the FDA adverse event reporting system (FAERS) database
    Shen, Junyi
    Lin, Anqi
    Cheng, Quan
    Zhang, Jian
    Luo, Peng
    CANCER RESEARCH, 2024, 84 (06)
  • [27] Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
    Badran, Yousef R.
    Cohen, Justine, V
    Brastianos, Priscilla K.
    Parikh, Aparna R.
    Hong, Theodore S.
    Dougan, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [28] CONCURRENT THERAPY WITH IMMUNE CHECKPOINT INHIBITORS AND TNF BLOCKADE IN PATIENTS WITH GASTROINTESTINAL IMMUNE-RELATED ADVERSE EVENTS
    Badran, Yousef R.
    Leet, Donna
    Cohen, Justine V.
    Brastianos, Priscilla K.
    Parikh, Aparna
    Hong, Theodore S.
    Dougan, Michael
    GASTROENTEROLOGY, 2020, 158 (06) : S538 - S538
  • [29] Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy
    Das, Satya
    Ciombor, Kristen K.
    Haraldsdottir, Sigurdis
    Pumpalova, Yoanna
    Sahin, Ibrahim H.
    Pineda, G.
    Shyr, Yu
    Lin, E. P.
    Hsu, Chih-Yuan
    Chu, Shih-Kai
    Goff, Laura W.
    Cardin, Dana B.
    Bilen, Mehmet A.
    Fisher, George A.
    Wu, Christina
    Berlin, Jordan
    ONCOLOGIST, 2020, 25 (08): : 669 - 679
  • [30] Immune checkpoint inhibitor-related adverse cardiac events in patients with lung cancer: a systematic review and meta-analysis
    Xiao-Tong Zhang
    Nan Ge
    Zi-Jian Xiang
    Tao Liu
    Cancer Cell International, 22
12345